UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

The New England journal of medicine, 2020-05, Vol.382 (19), p.1800-1810

2020

Volltextzugriff (PDF)

Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes

Frontiers in immunology, 2018-12, Vol.9, p.3053-3053

2018

Volltextzugriff (PDF)

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206

2013

Volltextzugriff (PDF)

Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients

PloS one, 2019-06, Vol.14 (6), p.e0217572-e0217572

2019

Volltextzugriff (PDF)

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

The Journal of infectious diseases, 2014-02, Vol.209 (4), p.557-561

2014

Volltextzugriff (PDF)

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic

Vaccine, 2011-02, Vol.29 (9), p.1777-1782

2011

Volltextzugriff (PDF)

Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study

Transplantation, 2007-03, Vol.83 (5), p.577-581

2007

Volltextzugriff (PDF)

A randomized controlled trial of visible-light therapy for the prevention of oral mucositis

Oral oncology, 2011-02, Vol.47 (2), p.125-130

2011

Volltextzugriff (PDF)

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

Experimental hematology, 2001-03, Vol.29 (3), p.362-370

2001

Volltextzugriff (PDF)

Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial

Biology of blood and marrow transplantation, 2014, Vol.20 (1), p.58-65

2014

Volltextzugriff (PDF)

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Cancer, 2012-10, Vol.118 (19), p.4706-4714

2012

Volltextzugriff (PDF)

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Haematologica (Roma), 2006-06, Vol.91 (6), p.852-855

2006

Volltextzugriff (PDF)

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients

British journal of haematology, 2015-04, Vol.169 (1), p.44-56

2015

Volltextzugriff (PDF)

Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group

Blood, 2010-04, Vol.115 (17), p.3437-3446

2010

Volltextzugriff (PDF)

Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.726-733

2019

Volltextzugriff (PDF)

Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients

Supportive care in cancer, 2003-10, Vol.11 (10), p.674-677

2003

Volltextzugriff (PDF)

Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

American journal of hematology, 2017-10, Vol.92 (10), p.997-1003

2017

Volltextzugriff (PDF)

Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning

Pediatric blood & cancer, 2016-03, Vol.63 (3), p.535-540

2016

Volltextzugriff (PDF)

Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation

Pediatric blood & cancer, 2018-11, Vol.65 (11), p.e27312-n/a

2018

Volltextzugriff (PDF)

Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?

Journal of clinical oncology, 2010-09, Vol.28 (27), p.e456-e458

2010

Volltextzugriff (PDF)

Early cell-cycle gene expression in T-cells after hematopoietic stem cell transplantation

Transplant immunology, 2013-12, Vol.29 (1), p.146-154

2013

Volltextzugriff (PDF)

Intra‐arterial catheter directed therapy for severe graft‐versus‐host disease

British journal of haematology, 2002-12, Vol.119 (3), p.760-764

2002

Volltextzugriff (PDF)

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

Blood, 2006-07, Vol.108 (1), p.88-96

2006

Volltextzugriff (PDF)

Early-Onset Guillain-Barré Syndrome Associated with Reactivation of Epstein-Barr Virus Infection after Nonmyeloablative Stem Cell Transplantation

Clinical infectious diseases, 2004-10, Vol.39 (7), p.1076-1078

2004

Volltextzugriff (PDF)

1 – 25 von 1.044

Suche als RSS-Feed

Aktive Filter

ThemaPhysics

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(972)
Mit Volltextzugriff
(872)

Publikationsform

Artikel
(1.044)

Sprache

Englisch
(1.040)
Hebräisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic

Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study

A randomized controlled trial of visible-light therapy for the prevention of oral mucositis

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients

Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity

Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients

Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning

Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation

Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?

Early cell-cycle gene expression in T-cells after hematopoietic stem cell transplantation

Intra‐arterial catheter directed therapy for severe graft‐versus‐host disease

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

Early-Onset Guillain-Barré Syndrome Associated with Reactivation of Epstein-Barr Virus Infection after Nonmyeloablative Stem Cell Transplantation

Aktive Filter

Suchergebnisse filtern